Then we validated that upregulation of UCA1 eliminates sensitivity of HCC to OXA through activating AKT/mTOR pathway in vitro and in vivo, whereas the response efficacy of OXA in HCC is restored after decreasing the expression of UCA1. The gene discussed is MTOR; the disease is hepatocellular carcinoma.